Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 16, Issue 24, pp. 6139-6149
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 15, 2010
- Revision received September 2, 2010
- Accepted September 15, 2010
- Published first September 27, 2010.
Article Versions
- Previous version (September 27, 2010 - 08:02).
- You are viewing the most recent version of this article.
Copyright & Usage
©2010 American Association for Cancer Research.
Author Information
- Steven K. Libutti1,
- Giulio F. Paciotti2,
- Adriana A. Byrnes3,
- H. Richard Alexander Jr.1,
- William E. Gannon4,
- Melissa Walker1,
- Geoffrey D. Seidel3,
- Nargiza Yuldasheva1, and
- Lawrence Tamarkin2
- Authors' Affiliations: 1Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; 2CytImmune Sciences, Inc., Rockville, Maryland; 3Clinical Monitoring Research Program, SAIC-Frederick, Inc., National Canver Institute-Frederick, Frederick, Maryland; and 4Capital City Technical Consulting, Inc., Washington, District of Columbia
- Corresponding Author:
Lawrence Tamarkin, CytImmune Sciences, Inc., 9640 Medical Center Drive, Rockville, MD 20850. Phone: 301-332-4459; E-mail: ltamarkin{at}cytimmune.com
December 2010
Volume 16, Issue 24
Volume 16, Issue 24
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Jump to section
Advertisement